Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Innoviva Inc (NASDAQ:INVA)

13.26
Delayed Data
As of 1:00pm ET
 -0.16 / -1.19%
Today’s Change
10.07
Today|||52-Week Range
14.87
+23.93%
Year-to-Date

Today’s Trading

Previous close13.42
Today’s open13.48
Day’s range13.19 - 13.51
Volume302,432
Average volume (3 months)1,027,430
Market cap$1.4B
Dividend yield--
Data as of 1:00pm ET, 11/24/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+107.17%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+117.48%
P/E ratio14.9
Price/Sales8.95
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PCRXPacira Pharmaceutica...+1.45+3.26%
EBSEmergent BioSolution...+0.81+1.98%
MYOKMyoKardia Inc-0.45-1.26%
LXRXLexicon Pharmaceutic...0.000.00%
Data as of 1:02pm ET, 11/24/2017

Financials

Next reporting dateFebruary 8, 2018
EPS forecast (this quarter)$0.40
Annual revenue (last year)$147.4M
Annual profit (last year)$59.5M
Net profit margin40.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
Brisbane, California

Forecasts